Evolution of cytokines/chemokines in cases with community‐acquired pneumonia and distinct etiologies

Aim To compare the systemic cytokines/chemokines levels over time during the evolution of children hospitalized with community‐acquired pneumonia (CAP) with and without pneumococcal infection. Methods Children less than 5‐years‐old hospitalized with CAP were prospectively investigated in Salvador, B...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric pulmonology 2020-01, Vol.55 (1), p.169-176
Hauptverfasser: Nascimento‐Carvalho, Eduardo C., Vasconcellos, Ângela G., Clarêncio, Jorge, Andrade, Daniela, Barral, Aldina, Barral‐Netto, Manoel, Nascimento‐Carvalho, Cristiana M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 176
container_issue 1
container_start_page 169
container_title Pediatric pulmonology
container_volume 55
creator Nascimento‐Carvalho, Eduardo C.
Vasconcellos, Ângela G.
Clarêncio, Jorge
Andrade, Daniela
Barral, Aldina
Barral‐Netto, Manoel
Nascimento‐Carvalho, Cristiana M.
description Aim To compare the systemic cytokines/chemokines levels over time during the evolution of children hospitalized with community‐acquired pneumonia (CAP) with and without pneumococcal infection. Methods Children less than 5‐years‐old hospitalized with CAP were prospectively investigated in Salvador, Brazil. Clinical data and biological samples were collected to investigate 20 etiological agents and to determine serum cytokines/chemokines levels on admission and 2 to 4 weeks later. Cases with pneumococcal infection received this diagnosis irrespective of also having other etiologies. Results A total of 277 patients were enrolled, however, serum sample was unavailable for cytokine measurement upon admission (n = 61) or upon follow‐up visit (n = 36), etiology was undetected (n = 50) and one patient did not attend the follow‐up visit. Therefore, this study group comprised of 129 cases with established etiology. The median (interquartile range) age and sampling interval was 18 (9‐27) months and 18 (16‐21) days, respectively. Established etiology was viral (52.0%), viral‐bacterial (30.2%), and bacterial (17.8%). Pneumococcal infection was found in 31 (24.0%) patients. Overall, median interleukin‐6 (IL‐6; 10.6 [4.7‐30.6] vs 21.0 [20.2‐21.7]; P = .03), IL‐10 (3.5 [3.1‐4.5] vs 20.1 [19.8‐20.4]; P 
doi_str_mv 10.1002/ppul.24533
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2297128123</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2297128123</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3933-9229a503238bc5e7da9758ec6739eb1c4a9a7455da7627449c546862cedb2a13</originalsourceid><addsrcrecordid>eNp9kM1O3DAURi1UVKbQTR8AWeqmqpTBP3EcL9FoSiuNBAtYWx7nDmOa2CGOGc2uj9Bn5ElqGmDBgtX9pHt0dO-H0BdK5pQQdtb3qZ2zUnB-gGaUKFWQUlUf0KyWQhRVXfEj9CnGO0LyTtGP6IhTIbhgcoY2y4fQptEFj8MG2_0YfjsP8cxuoZsidh5bE3PYuXGLbei65N24f_zz19j75AZocO8hdcE7g41vcOPi6LwdMWRvG24dxBN0uDFthM_P8xhd_1heL34Wq8uLX4vzVWG54rxQjCkjCGe8XlsBsjFKihpsJbmCNbWlUUaWQjRGVkyWpbKizP8xC82aGcqP0bdJ2w_hPkEcdeeihbY1HkKKOuslZTVlPKNf36B3IQ0-H6cZZ3VVVqJSmfo-UXYIMQ6w0f3gOjPsNSX6qXz9VL7-X36GT5-Vad1B84q-tJ0BOgE718L-HZW-urpZTdJ_tFORXg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2328646569</pqid></control><display><type>article</type><title>Evolution of cytokines/chemokines in cases with community‐acquired pneumonia and distinct etiologies</title><source>Wiley Online Library All Journals</source><creator>Nascimento‐Carvalho, Eduardo C. ; Vasconcellos, Ângela G. ; Clarêncio, Jorge ; Andrade, Daniela ; Barral, Aldina ; Barral‐Netto, Manoel ; Nascimento‐Carvalho, Cristiana M.</creator><creatorcontrib>Nascimento‐Carvalho, Eduardo C. ; Vasconcellos, Ângela G. ; Clarêncio, Jorge ; Andrade, Daniela ; Barral, Aldina ; Barral‐Netto, Manoel ; Nascimento‐Carvalho, Cristiana M.</creatorcontrib><description>Aim To compare the systemic cytokines/chemokines levels over time during the evolution of children hospitalized with community‐acquired pneumonia (CAP) with and without pneumococcal infection. Methods Children less than 5‐years‐old hospitalized with CAP were prospectively investigated in Salvador, Brazil. Clinical data and biological samples were collected to investigate 20 etiological agents and to determine serum cytokines/chemokines levels on admission and 2 to 4 weeks later. Cases with pneumococcal infection received this diagnosis irrespective of also having other etiologies. Results A total of 277 patients were enrolled, however, serum sample was unavailable for cytokine measurement upon admission (n = 61) or upon follow‐up visit (n = 36), etiology was undetected (n = 50) and one patient did not attend the follow‐up visit. Therefore, this study group comprised of 129 cases with established etiology. The median (interquartile range) age and sampling interval was 18 (9‐27) months and 18 (16‐21) days, respectively. Established etiology was viral (52.0%), viral‐bacterial (30.2%), and bacterial (17.8%). Pneumococcal infection was found in 31 (24.0%) patients. Overall, median interleukin‐6 (IL‐6; 10.6 [4.7‐30.6] vs 21.0 [20.2‐21.7]; P = .03), IL‐10 (3.5 [3.1‐4.5] vs 20.1 [19.8‐20.4]; P &lt; .001), and CCL2 (19.3 [12.4‐23.2] vs 94.0 [67.2‐117.8]; P &lt; .001) were significantly higher in convalescent serum samples, whereas median CXCL10 (83.6 [36.4‐182.9] vs 14.6 [0‐116.6]; P &lt; .001) was lower. Acute vs convalescent levels evolution of IL‐10, CCL2, and CXCL10 did not differ among patients with or without pneumococcal infection. However, IL‐6 decreased (27.8 [12.3‐48.6] vs 20.8 [20.2‐22.6]; P = .1) in patients with pneumococcal infection and increased (9.0 [4.2‐22.6] vs 21.0 [20.2‐21.7]; P = .001) in patients without it. Conclusion The marked increase of IL‐6 serum levels during the acute phase makes it a potential biomarker of pneumococcal infection among children with CAP.</description><identifier>ISSN: 8755-6863</identifier><identifier>EISSN: 1099-0496</identifier><identifier>DOI: 10.1002/ppul.24533</identifier><identifier>PMID: 31553527</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>acute respiratory infection ; Chemokines ; child ; Cytokines ; Etiology ; Evolution ; Infections ; lower respiratory tract infection ; lung disease ; pneumococcal infection ; Pneumonia</subject><ispartof>Pediatric pulmonology, 2020-01, Vol.55 (1), p.169-176</ispartof><rights>2019 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3933-9229a503238bc5e7da9758ec6739eb1c4a9a7455da7627449c546862cedb2a13</citedby><cites>FETCH-LOGICAL-c3933-9229a503238bc5e7da9758ec6739eb1c4a9a7455da7627449c546862cedb2a13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fppul.24533$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fppul.24533$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27922,27923,45572,45573</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31553527$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nascimento‐Carvalho, Eduardo C.</creatorcontrib><creatorcontrib>Vasconcellos, Ângela G.</creatorcontrib><creatorcontrib>Clarêncio, Jorge</creatorcontrib><creatorcontrib>Andrade, Daniela</creatorcontrib><creatorcontrib>Barral, Aldina</creatorcontrib><creatorcontrib>Barral‐Netto, Manoel</creatorcontrib><creatorcontrib>Nascimento‐Carvalho, Cristiana M.</creatorcontrib><title>Evolution of cytokines/chemokines in cases with community‐acquired pneumonia and distinct etiologies</title><title>Pediatric pulmonology</title><addtitle>Pediatr Pulmonol</addtitle><description>Aim To compare the systemic cytokines/chemokines levels over time during the evolution of children hospitalized with community‐acquired pneumonia (CAP) with and without pneumococcal infection. Methods Children less than 5‐years‐old hospitalized with CAP were prospectively investigated in Salvador, Brazil. Clinical data and biological samples were collected to investigate 20 etiological agents and to determine serum cytokines/chemokines levels on admission and 2 to 4 weeks later. Cases with pneumococcal infection received this diagnosis irrespective of also having other etiologies. Results A total of 277 patients were enrolled, however, serum sample was unavailable for cytokine measurement upon admission (n = 61) or upon follow‐up visit (n = 36), etiology was undetected (n = 50) and one patient did not attend the follow‐up visit. Therefore, this study group comprised of 129 cases with established etiology. The median (interquartile range) age and sampling interval was 18 (9‐27) months and 18 (16‐21) days, respectively. Established etiology was viral (52.0%), viral‐bacterial (30.2%), and bacterial (17.8%). Pneumococcal infection was found in 31 (24.0%) patients. Overall, median interleukin‐6 (IL‐6; 10.6 [4.7‐30.6] vs 21.0 [20.2‐21.7]; P = .03), IL‐10 (3.5 [3.1‐4.5] vs 20.1 [19.8‐20.4]; P &lt; .001), and CCL2 (19.3 [12.4‐23.2] vs 94.0 [67.2‐117.8]; P &lt; .001) were significantly higher in convalescent serum samples, whereas median CXCL10 (83.6 [36.4‐182.9] vs 14.6 [0‐116.6]; P &lt; .001) was lower. Acute vs convalescent levels evolution of IL‐10, CCL2, and CXCL10 did not differ among patients with or without pneumococcal infection. However, IL‐6 decreased (27.8 [12.3‐48.6] vs 20.8 [20.2‐22.6]; P = .1) in patients with pneumococcal infection and increased (9.0 [4.2‐22.6] vs 21.0 [20.2‐21.7]; P = .001) in patients without it. Conclusion The marked increase of IL‐6 serum levels during the acute phase makes it a potential biomarker of pneumococcal infection among children with CAP.</description><subject>acute respiratory infection</subject><subject>Chemokines</subject><subject>child</subject><subject>Cytokines</subject><subject>Etiology</subject><subject>Evolution</subject><subject>Infections</subject><subject>lower respiratory tract infection</subject><subject>lung disease</subject><subject>pneumococcal infection</subject><subject>Pneumonia</subject><issn>8755-6863</issn><issn>1099-0496</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kM1O3DAURi1UVKbQTR8AWeqmqpTBP3EcL9FoSiuNBAtYWx7nDmOa2CGOGc2uj9Bn5ElqGmDBgtX9pHt0dO-H0BdK5pQQdtb3qZ2zUnB-gGaUKFWQUlUf0KyWQhRVXfEj9CnGO0LyTtGP6IhTIbhgcoY2y4fQptEFj8MG2_0YfjsP8cxuoZsidh5bE3PYuXGLbei65N24f_zz19j75AZocO8hdcE7g41vcOPi6LwdMWRvG24dxBN0uDFthM_P8xhd_1heL34Wq8uLX4vzVWG54rxQjCkjCGe8XlsBsjFKihpsJbmCNbWlUUaWQjRGVkyWpbKizP8xC82aGcqP0bdJ2w_hPkEcdeeihbY1HkKKOuslZTVlPKNf36B3IQ0-H6cZZ3VVVqJSmfo-UXYIMQ6w0f3gOjPsNSX6qXz9VL7-X36GT5-Vad1B84q-tJ0BOgE718L-HZW-urpZTdJ_tFORXg</recordid><startdate>202001</startdate><enddate>202001</enddate><creator>Nascimento‐Carvalho, Eduardo C.</creator><creator>Vasconcellos, Ângela G.</creator><creator>Clarêncio, Jorge</creator><creator>Andrade, Daniela</creator><creator>Barral, Aldina</creator><creator>Barral‐Netto, Manoel</creator><creator>Nascimento‐Carvalho, Cristiana M.</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>202001</creationdate><title>Evolution of cytokines/chemokines in cases with community‐acquired pneumonia and distinct etiologies</title><author>Nascimento‐Carvalho, Eduardo C. ; Vasconcellos, Ângela G. ; Clarêncio, Jorge ; Andrade, Daniela ; Barral, Aldina ; Barral‐Netto, Manoel ; Nascimento‐Carvalho, Cristiana M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3933-9229a503238bc5e7da9758ec6739eb1c4a9a7455da7627449c546862cedb2a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>acute respiratory infection</topic><topic>Chemokines</topic><topic>child</topic><topic>Cytokines</topic><topic>Etiology</topic><topic>Evolution</topic><topic>Infections</topic><topic>lower respiratory tract infection</topic><topic>lung disease</topic><topic>pneumococcal infection</topic><topic>Pneumonia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nascimento‐Carvalho, Eduardo C.</creatorcontrib><creatorcontrib>Vasconcellos, Ângela G.</creatorcontrib><creatorcontrib>Clarêncio, Jorge</creatorcontrib><creatorcontrib>Andrade, Daniela</creatorcontrib><creatorcontrib>Barral, Aldina</creatorcontrib><creatorcontrib>Barral‐Netto, Manoel</creatorcontrib><creatorcontrib>Nascimento‐Carvalho, Cristiana M.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric pulmonology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nascimento‐Carvalho, Eduardo C.</au><au>Vasconcellos, Ângela G.</au><au>Clarêncio, Jorge</au><au>Andrade, Daniela</au><au>Barral, Aldina</au><au>Barral‐Netto, Manoel</au><au>Nascimento‐Carvalho, Cristiana M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evolution of cytokines/chemokines in cases with community‐acquired pneumonia and distinct etiologies</atitle><jtitle>Pediatric pulmonology</jtitle><addtitle>Pediatr Pulmonol</addtitle><date>2020-01</date><risdate>2020</risdate><volume>55</volume><issue>1</issue><spage>169</spage><epage>176</epage><pages>169-176</pages><issn>8755-6863</issn><eissn>1099-0496</eissn><abstract>Aim To compare the systemic cytokines/chemokines levels over time during the evolution of children hospitalized with community‐acquired pneumonia (CAP) with and without pneumococcal infection. Methods Children less than 5‐years‐old hospitalized with CAP were prospectively investigated in Salvador, Brazil. Clinical data and biological samples were collected to investigate 20 etiological agents and to determine serum cytokines/chemokines levels on admission and 2 to 4 weeks later. Cases with pneumococcal infection received this diagnosis irrespective of also having other etiologies. Results A total of 277 patients were enrolled, however, serum sample was unavailable for cytokine measurement upon admission (n = 61) or upon follow‐up visit (n = 36), etiology was undetected (n = 50) and one patient did not attend the follow‐up visit. Therefore, this study group comprised of 129 cases with established etiology. The median (interquartile range) age and sampling interval was 18 (9‐27) months and 18 (16‐21) days, respectively. Established etiology was viral (52.0%), viral‐bacterial (30.2%), and bacterial (17.8%). Pneumococcal infection was found in 31 (24.0%) patients. Overall, median interleukin‐6 (IL‐6; 10.6 [4.7‐30.6] vs 21.0 [20.2‐21.7]; P = .03), IL‐10 (3.5 [3.1‐4.5] vs 20.1 [19.8‐20.4]; P &lt; .001), and CCL2 (19.3 [12.4‐23.2] vs 94.0 [67.2‐117.8]; P &lt; .001) were significantly higher in convalescent serum samples, whereas median CXCL10 (83.6 [36.4‐182.9] vs 14.6 [0‐116.6]; P &lt; .001) was lower. Acute vs convalescent levels evolution of IL‐10, CCL2, and CXCL10 did not differ among patients with or without pneumococcal infection. However, IL‐6 decreased (27.8 [12.3‐48.6] vs 20.8 [20.2‐22.6]; P = .1) in patients with pneumococcal infection and increased (9.0 [4.2‐22.6] vs 21.0 [20.2‐21.7]; P = .001) in patients without it. Conclusion The marked increase of IL‐6 serum levels during the acute phase makes it a potential biomarker of pneumococcal infection among children with CAP.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31553527</pmid><doi>10.1002/ppul.24533</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 8755-6863
ispartof Pediatric pulmonology, 2020-01, Vol.55 (1), p.169-176
issn 8755-6863
1099-0496
language eng
recordid cdi_proquest_miscellaneous_2297128123
source Wiley Online Library All Journals
subjects acute respiratory infection
Chemokines
child
Cytokines
Etiology
Evolution
Infections
lower respiratory tract infection
lung disease
pneumococcal infection
Pneumonia
title Evolution of cytokines/chemokines in cases with community‐acquired pneumonia and distinct etiologies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T12%3A41%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evolution%20of%20cytokines/chemokines%20in%20cases%20with%20community%E2%80%90acquired%20pneumonia%20and%20distinct%20etiologies&rft.jtitle=Pediatric%20pulmonology&rft.au=Nascimento%E2%80%90Carvalho,%20Eduardo%20C.&rft.date=2020-01&rft.volume=55&rft.issue=1&rft.spage=169&rft.epage=176&rft.pages=169-176&rft.issn=8755-6863&rft.eissn=1099-0496&rft_id=info:doi/10.1002/ppul.24533&rft_dat=%3Cproquest_cross%3E2297128123%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2328646569&rft_id=info:pmid/31553527&rfr_iscdi=true